November 9, 2010 / 6:33 PM / in 7 years

UPDATE 1-AEterna Zentaris loss narrows, revenue falls

* Q3 loss $0.12/shr vs loss $0.19/shr

* Revenue down 33.7 percent at $5.7 mln (In U.S. dollars unless noted)

TORONTO, Nov 9 (Reuters) - Drugmaker AEterna Zentaris AEZ.TO posted a narrower quarterly loss on Tuesday, citing lower expenses, which offset lower revenues and higher foreign exchange losses.

Quebec City-based AEterna, which specializes in developing drugs for treating cancer, said it had a third quarter loss of $10.1 million, or 12 cents a share, for the three months ended Sept. 30. That compared with a loss of $11.3 million, or 19 cents a share, a year earlier.

Revenue fell 33.7 percent to $5.7 million.

AEterna shares were down 0.8 percent at C$1.23 on the Toronto Stock Exchange early Tuesday afternoon.

$1=$1.00 Canadian Reporting by Solarina Ho; editing by Rob Wilson

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below